NCT04444583Completed
Recognition of Heart Failure With Micro Electro-Mechanical Sensors (REFLECS) FI
Source: ClinicalTrials.gov · Last updated 14 Jul 2025
Brief summary (registry, in English)
In this study the ability of smartphone sensors (accelerometer and gyroscope) to identify patients with heart failure will be studied.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 155 (actual)
- First submitted
- 17 Jun 2020
- Start date
- 1 Jun 2020
- Primary completion date
- 31 Dec 2021
- Lead sponsor
- Precordior Ltd
- Diseases
- Heart failure
- NCT number
- NCT04444583
What you commit to
- Study type: Observational
- Participants enrolled: 155
- From 1 Jun 2020 to the primary completion date, 31 Dec 2021
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Age \<18 years
- Severe cardiac valve disease
- Previous prosthetic cardiac valve
- Major adverse cardiovascular event or surgery within 6 weeks of planned study enrollment
- Patients with pacemaker
- Informed consent form not signed.
Who the study is looking for
- Age \>18 years
- Patients visiting hospital for heart failure, either outpatient clinic or cardiac ward
- Signed informed consent as an acceptance to participate to the trial
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Heart and Lung Center at Helsinki University Hospital Coordinator of this site? Confirm its status | Helsinki | Finland | Unknown status |
| Heart Center at Turku University Hospital Coordinator of this site? Confirm its status | Turku | Finland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.